Drug
Litifilimab
Litifilimab: highest development phase Phase 3, developed by Biogen. 3 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Biogen
Trials
| Drug | Phase | Indication |
|---|---|---|
| Litifilimab NCT05352919 | Phase 3 | Systemic Lupus Erythematosus (SLE) |
| Litifilimab NCT05531565 | Phase 2/3 | Subacute Cutaneous Lupus Erythematosus |
| Litifilimab NCT06741657 | Phase 1 | Healthy Volunteer |
Latest
No recent events.
Follow Litifilimab on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.